News
Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...
Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.
1h
WISH-TV on MSNFDA-approved semaglutide aids weight loss and health conditions
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
States along the Gulf Coast have raised alarms about a rise in infections from flesh-eating bacteria. In Louisiana, doctors ...
Liver checks are being offered at supermarkets and football matches and in offices as part of efforts to catch cancer early.
Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that ...
Thousands of people across England have been referred for liver cancer checks following the expansion of mobile scanning ...
Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that ...
8h
GlobalData on MSNNHS’ mobile trucks enhance liver cancer health checks
The National Health Service (NHS) in the UK has expanded its community liver health check programme through scanning trucks, ...
Bloating, often dismissed as a minor digestive issue, can signal underlying health problems beyond gut issues. It may stem ...
Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results